Clinical Guideline To Manage GSM in Women With Breast Cancer

The North American Menopause Society (NAMS) and The International Society for the Study of Women's Sexual Health (ISSWSH) have together formed a multidisciplinary Consensus Panel to develop a new guideline for clinicians to manage genitourinary syndrome of menopause (GSM) in women with or at high risk for breast cancer. GSM is often prevalent in women survivors of breast cancer survivors, as compared to other menopausal women, and commonly left undiagnosed and untreated. This guideline is published in NAMS' official journal, Menopause.//

For survivors of breast cancer, not only is GSM more prevalent, but these women may experience its symptoms earlier because of cancer treatments. With the lack of data regarding the safety of vaginal hormone treatments and other alternatives for women with or at high risk for breast cancer, many have avoided using hormone treatments, and clinicians have often been reluctant to prescribe them.

Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.

‘Recommendations to provide clinicians with an approach to managing GSM in women with or at high risk for breast cancer were released by The North American Menopause Society (NAMS) and The International Society for the Study of Women's Sexual Health (ISSWSH).’

Tweet it Now

Left untreated, GSM can potentially adversely affect quality of life and partner relationships because of ongoing symptoms, including vulvovaginal dryness, burning, or irritation; painful intercourse; and recurrent urinary tract infections. It is estimated that more than 2 million survivors of breast cancer in the United States are affected by GSM, with most receiving no treatment.

The Consensus Panel of 16 experts created the consensus recommendations after a comprehensive, evidence-based review of existing literature. In addition, the Consensus Panel agreed that decision making regarding the type of treatment for GSM should be individualized and include balancing the risk of cancer recurrence with the severity of symptoms and effect on quality of life. The recommendations offer clinicians caring for this population of women some guidance regarding therapeutic decision making in the absence of clinical trial data.

"We want clinicians caring for this at-risk population to be armed with as much information as possible so that they can provide the best course of treatment for their patients," says Dr. JoAnn Pinkerton, executive director of NAMS. "Until additional studies are undertaken in this area, we are hopeful these consensus recommendations will provide added confidence for clinicians to move forward with treatment options that will provide relief to women from GSM symptoms."

Inflammatory Breast Cancer - Causes, Symptoms, Diagnosis, Treatment & Prognosis
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.

Source-Eurekalert

Screening for Breast Cancer with Clinical Breast Examination
Clinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography.

Triple-Negative Breast Cancer - Causes, Symptoms, Diagnosis, Treatment, Prevention & Prognosis
Triple-negative breast cancers are ER negative, PR negative, and lack overexpression of HER-2. They are difficult to treat and are very aggressive.